Cardiology - Cardiology Xagena

CardiologyOnline

News

Drugs

Xagena Medicine

Xagena.net

Vitamin E can increase the risk for heart failure

Addition of Clopidogrel to Aspirin and fibrinolytic therapy proves beneficial for myocardial infarction

Drug-eluting stent: Cypher and Taxus, comparable efficacy in preventing in-segment binary restenosis

Dietary fiber intake reduces blood pressure in patients with hypertension

FDA: Crestor, favorable risk/benefit ratio

FDA has approved Candesartan Cilexetil for the treatment of heart failure

Treatment of systolic hypertension in older patients with SBP of at least 160 mm Hg is supported by strong evidence

A to Z Trial , Z phase : Simvastatin did not achieve the prespecified end point

ACTION trial : addition of Nifedipine GITS to conventional treatment of angina pectoris has no effect on major cardiovascular event-free survival

Next Pages «

Link

• Allergology

• Biomedicine

• Dermatology

• Diabetology

• Diagnostics

• Drugs

• Endocrinology

• Gastroenterology

• Gene Medicine

• Infectivology

• Ophthalmology

• Pharmacology

• Rheumatology

• Stem Therapy

n Xagena.it

Powered by Luca Malattia - LM Web Solutions